Work

Baseline tumor T cell receptor (TcR) sequencing analysis and neo antigen load is associated with benefit in melanoma patients receiving sequential nivolumab and ipilimumab

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw378.01

Authors: J. Weber, C. Horak, F.S. Hodi, H. Chang, D. Woods, C. Sanders, H. Robins, E. Yusko

Institutions: NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, Bristol-Myers Squibb (United States), Dana-Farber Cancer Institute, Adaptive Biotechnologies (United States), Fred Hutch Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2588001063

FWCI: 1.258

Cites:

Cited by: 13

Related to: 10